These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25817494)

  • 1. [Problems identified in the package leaflets of the Portuguese non-generic medicines].
    Pires C; Cavaco A; Vigário M
    Acta Med Port; 2015; 28(1):21-8. PubMed ID: 25817494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Package leaflets of the most consumed medicines in Portugal: safety and regulatory compliance issues. A descriptive study.
    Pires C; Vigário M; Cavaco A
    Sao Paulo Med J; 2015; 133(2):91-100. PubMed ID: 25337666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readability Analysis of the Package Leaflets for Biological Medicines Available on the Internet Between 2007 and 2013: An Analytical Longitudinal Study.
    Piñero-López MÁ; Modamio P; Lastra CF; Mariño EL
    J Med Internet Res; 2016 May; 18(5):e100. PubMed ID: 27226241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Readability assessment of package leaflets of biosimilars.
    Piñero-López MÁ; Figueiredo-Escribá C; Modamio P; Lastra CF; Mariño EL
    BMJ Open; 2019 Jan; 9(1):e024837. PubMed ID: 30659042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Readability of medicinal package leaflets: a systematic review.
    Pires C; Vigário M; Cavaco A
    Rev Saude Publica; 2015; 49():4. PubMed ID: 25741660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of brand names of medicines: linguistic and format issues.
    Pires C; Cavaco A; Vigário M
    Int J Pharm Pract; 2017 Jun; 25(3):231-237. PubMed ID: 27677527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of the European QRD Template in Package Leaflets of Centralized Approved Medicines.
    Wolf A; Fuchs J; Schweim HG
    Ther Innov Regul Sci; 2016 Jan; 50(1):106-114. PubMed ID: 30236020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a new tool for evaluating subjects' satisfaction with medicine package leaflets: a cross-sectional descriptive study.
    Pires C; Rosa PJ; Vigário M; Cavaco A
    Sao Paulo Med J; 2019; 137(5):454-462. PubMed ID: 31939571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug package inserts--varying information for the same medicines].
    Storflor JG; Pettersen LC; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2013 May; 133(9):955-9. PubMed ID: 23652143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Medicines in Portugal: A Retrospective Review of Medicine Recalls (2000-2015).
    Machado Reis AT; Berardo BFR; Loureiro R
    PDA J Pharm Sci Technol; 2018; 72(1):44-49. PubMed ID: 29030530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Legibility analysis of drug package leaflets using Flesch-Sszigriszt index and Inflesz score].
    Ballesteros-Peña S; Fernández-Aedo I
    An Sist Sanit Navar; 2013; 36(3):397-406. PubMed ID: 24406353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of health literacy and the readability of information leaflets].
    Cavaco A; Santos AL
    Rev Saude Publica; 2012 Oct; 46(5):918-22. PubMed ID: 23128269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'What do patients want?' Tailoring medicines information to meet patients' needs.
    Young A; Tordoff J; Smith A
    Res Social Adm Pharm; 2017 Nov; 13(6):1186-1190. PubMed ID: 27818214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of German package inserts.
    Fuchs J; Hippius M; Schaefer M
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):8-13. PubMed ID: 16425965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Grammatical readability of the package leaflets of the medicinal products most widely consumed and generating the highest expense in Spain during 2005].
    Barrio-Cantalejo IM; Simón-Lorda P; March Cerdá JC; Prieto Rodríguez MA
    Rev Esp Salud Publica; 2008; 82(5):559-66. PubMed ID: 19039508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review.
    Tong V; Raynor DK; Aslani P
    Int J Clin Pharm; 2014 Oct; 36(5):865-72. PubMed ID: 24980281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical information in drug package inserts in India.
    Shivkar YM
    J Postgrad Med; 2009; 55(2):104-7. PubMed ID: 19550054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that Facilitate and Hinder the Comprehension of Patient Information Leaflets (PILs): A Brief Scoping Review.
    Medina-Córdoba M; Cadavid S; Pérez-Acosta AM; Amaya-Giraldo V
    Front Pharmacol; 2021; 12():740334. PubMed ID: 34858174
    [No Abstract]   [Full Text] [Related]  

  • 19. The possible harms of statins: What do product labels, patient package inserts, and pharmacy leaflets tell us?
    Doshi P; Sieluk J; Hung A
    J Am Pharm Assoc (2003); 2019; 59(2):195-201. PubMed ID: 30661956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient information leaflets--patients' comprehension of information about interactions and contraindications.
    Gustafsson J; Kälvemark S; Nilsson G; Nilsson JL
    Pharm World Sci; 2005 Feb; 27(1):35-40. PubMed ID: 15861933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.